| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman, PRISMA Group* Annals of internal medicine 151 (4), 264-269, 2009 | 161084* | 2009 |
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman, PRISMA Group* Annals of internal medicine 151 (4), 264-269, 2009 | 134363 | 2009 |
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman, PRISMA Group* Annals of internal medicine 151 (4), 264-269, 2009 | 133835 | 2009 |
| Statistical methods for assessing agreement between two methods of clinical measurements JM Blaud, DG Altman Lancet 12, 307-310, 1986 | 54726 | 1986 |
| Statistical methods for assessing agreement between two methods of clinical measurement JM Bland, DG Altman The lancet 327 (8476), 307-310, 1986 | 54702 | 1986 |
| Measuring inconsistency in meta-analyses JPT Higgins, SG Thompson, JJ Deeks, DG Altman Bmj 327 (7414), 557-560, 2003 | 51474 | 2003 |
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration A Liberati, DG Altman, J Tetzlaff, C Mulrow, PC Gøtzsche, JPA Ioannidis, ... Annals of internal medicine 151 (4), W-65-W-94, 2009 | 48261 | 2009 |
| The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies E Von Elm, DG Altman, M Egger, SJ Pocock, PC Gøtzsche, ... The Lancet 370 (9596), 1453-1457, 2007 | 43826* | 2007 |
| The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies E Von Elm, DG Altman, M Egger, SJ Pocock, PC Gøtzsche, ... The Lancet 370 (9596), 1453-1457, 2007 | 43062* | 2007 |
| The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies E Von Elm, DG Altman, M Egger, SJ Pocock, PC Gøtzsche, ... The Lancet 370 (9596), 1453-1457, 2007 | 42919* | 2007 |
| The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials JPT Higgins, DG Altman, PC Gøtzsche, P Jüni, D Moher, AD Oxman, ... Bmj 343, 2011 | 27001 | 2011 |
| Practical statistics for medical research DG Altman CRC press, 1990 | 25358 | 1990 |
| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 16148 | 2017 |
| QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies PF Whiting, AWS Rutjes, ME Westwood, S Mallett, JJ Deeks, JB Reitsma, ... Annals of internal medicine 155 (8), 529-536, 2011 | 10798 | 2011 |
| ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions JAC Sterne, MA Hernán, BC Reeves, J Savović, ND Berkman, ... bmj 355, 2016 | 10282 | 2016 |
| Measuring agreement in method comparison studies JM Bland, DG Altman Statistical methods in medical research 8 (2), 135-160, 1999 | 9879 | 1999 |
| The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials D Moher, KF Schulz, DG Altman, CONSORT Group* Annals of internal medicine 134 (8), 657-662, 2001 | 9719 | 2001 |
| Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration JP Vandenbroucke, E Elm, DG Altman, PC Gøtzsche, CD Mulrow, ... Annals of internal medicine 147 (8), W-163-W-194, 2007 | 9233 | 2007 |
| Assessing risk of bias in included studies JPT Higgins, DG Altman Cochrane handbook for systematic reviews of interventions: Cochrane book …, 2008 | 8395* | 2008 |
| Statistics notes: Cronbach's alpha JM Bland, DG Altman Bmj 314 (7080), 572, 1997 | 8279* | 1997 |
